OPM Mandates Behavioral Therapy for GLP-1 Medication Coverage Starting 2027

In a significant policy shift, the Office of Personnel Management (OPM) announced that all Federal Employees Health Benefits (FEHB) and Postal Service Health Benefits (PSHB) carriers will be required to track members’ participation in Intensive Behavioral Therapy (IBT) as a condition for providing coverage of anti-obesity medications, specifically the GLP-1 class of drugs. This requirement takes effect in the 2027 plan year and necessitates that adults undergo 12–22 sessions annually, while children and adolescents must complete at least 26 contact hours of behavioral therapy.

This move marks a considerable change in how health plans administer coverage for GLP-1 medications, impacting operational strategies for health insurers and behavioral health service providers. The policy aims to ensure that patients not only receive medication but also the necessary support to change behaviors contributing to obesity, a condition that continues to pose significant health risks to many Americans.

However, the new requirement brings substantial operational challenges. Carriers will need to thoroughly assess whether their existing programs, including digital platforms like Noom and CVS's weight management services, align with the newly established IBT documentation criteria. Moreover, timely access to care will be crucial; delays in obtaining behavioral therapy services could hinder patients' abilities to effectively use GLP-1 medications. Thus, health plans must evaluate their capacity, ensure seamless patient transitions between services, and address potential data-sharing issues with prescribing clinicians.

Enrollees have voiced mixed opinions regarding the new requirements, with some expressing concerns about the implications for their medical care. One commenter from CareFirst stated, "This took away my board-certified doctor’s ability to prescribe medication that will be covered, gives me less reason to use local healthcare facilities, and means my health information (labs, habits, etc.) is handed over to a private third party to make those decisions." Such sentiments underline the importance of clear communication from health plans regarding how these changes will affect patient care and prescribing practices.

As the 2027 plan year approaches, health plans and service providers must prepare for the significant changes that lie ahead. Stakeholders should proactively refine their strategies to provide comprehensive support for enrollee compliance with IBT requirements while maintaining the integrity of their care delivery processes. Failure to adapt could jeopardize coverage eligibility and lead to increased dissatisfaction among members.

Moving forward, it is critical for all stakeholders, including providers like Noom and CVS as well as carriers such as CareFirst and others, to assess their current service arrangements. A thorough review will help determine whether they can fulfill the IBT requirement without compromising patient care or operational efficiency.

Health plans must also build effective communication channels to update enrollees on how these changes will affect their healthcare pathways—especially regarding access to medications and behavioral therapy services—as part of broader efforts in supportive healthcare.

Ultimately, these developments signal a growing trend towards integrating behavioral health support with physical medication treatment, particularly in managing complex conditions such as obesity. The expansion of behavioral therapy requirements within the context of FEHB and PSHB represents a critical shift in perspective on the holistic treatment of obesity, encouraging ongoing investment in both medical and behavioral health solutions.

• OPM mandates that FEHB and PSHB carriers document IBT participation for GLP-1 medication coverage.
• Effective 2027, adults must complete 12-22 sessions of IBT; children need at least 26 contact hours.
• Health plans must evaluate their existing programs for compliance with the new IBT documentation.
• Concerns regarding operational impacts, patient care access, and data-sharing scrutiny have arisen among enrollees.
• Stakeholders must proactively prepare for changes to maintain patient satisfaction and coverage eligibility.
• Providers like Noom and CVS may need to reassess service offerings in light of these new requirements.